Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation

被引:85
|
作者
Yang, Chunguang [1 ]
Ma, Xueyou [1 ]
Wang, Zhihua [1 ]
Zeng, Xing [1 ]
Hu, Zhiquan [1 ]
Ye, Zhangqun [1 ]
Shen, Guanxin [2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan, Hubei, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
curcumin; castration-resistant prostate cancer; apoptosis; autophagy; iron chelation; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; HEPATOMA; EFFICACY; THERAPY;
D O I
10.2147/DDDT.S126964
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Curcumin induces apoptosis and autophagy in different cancer cells. Moreover, chemical and biological experiments have evidenced that curcumin is a biologically active iron chelator and induces cytotoxicity through iron chelation. We thus hypothesized that curcumin may induce apoptosis and autophagy in castration-resistant prostate cancer (CRPC) cells through its iron-chelating properties. Materials and methods: CRPC cells were loaded with curcumin alone or in combination with ferric ammonium citrate (FAC). Cytotoxicity was measured by 3-(4,5-dimethylthiazol2- yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was assessed by flow cytometry, terminal deoxynucleotidyl transferase nick end labeling (TUNEL) assay and caspase activity. Autophagy status was analyzed by the detection of autophagosomes and light chain 3-II (LC3-II) using transmission electron microscopy and Western blot. Iron-binding activity of curcumin was assessed by spectrophotometry and MTT assay. The expression levels of transferrin receptor 1 (TfR1) and iron regulatory protein 1 (IRP1) were examined by Western blot. Results: Curcumin induced apoptosis and autophagy in CRPC cells. Combining curcumin with autophagy inhibitors (3-methyladenine [3-MA]) synergized the apoptotic effect of curcumin. Moreover, curcumin bound to FAC at a ratio of similar to 1: 1, as assessed by spectrophotometry and MTT assay. Apoptosis and autophagy induced by curcumin were counteracted by equal amounts of FAC. At apoptosis-and autophagy-inducing concentrations, curcumin enhanced the expression levels of TfR1 and IRP1, indicative of iron deprivation induced by curcumin. Conclusion: Together, our results indicate that curcumin induces apoptosis and protective autophagy in CRPC cells, which are at least partially dependent on its iron-chelating properties.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
  • [21] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [22] Chemotherapy for castration-resistant prostate cancer
    Berthold, D.
    ONKOLOGIE, 2011, 34 : 12 - 12
  • [23] Strategies in castration-resistant prostate cancer
    Bessede, Th
    PROGRES EN UROLOGIE, 2011, 21 : S68 - S71
  • [24] Abiraterone and castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2013, 14 (02): : E48 - E48
  • [25] Diethylstilbestrol in castration-resistant prostate cancer
    Wilkins, Anna
    Shahidi, Mehdi
    Parker, Chris
    Gunapala, Ranga
    Thomas, Karen
    Huddart, Robert
    Horwich, Alan
    Dearnaley, David
    BJU INTERNATIONAL, 2012, 110 (11B) : E727 - E735
  • [26] The biology of castration-resistant prostate cancer
    Lian, Fei
    Sharma, Nitya V.
    Moran, Josue D.
    Moreno, Carlos S.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 17 - 28
  • [27] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    UROLOGE, 2014, 53 (03): : 391 - 399
  • [28] Steroidogenesis in castration-resistant prostate cancer
    Shiota, Masaki
    Endo, Satoshi
    Blas, Leandro
    Fujimoto, Naohiro
    Eto, Masatoshi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 240 - 251
  • [29] Cabazitaxel for castration-resistant prostate cancer
    Shigeta, Keisuke
    Miura, Yuji
    Naito, Yoichi
    Takano, Toshimi
    LANCET, 2011, 377 (9760): : 121 - 121
  • [30] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312